Inverting the Drug Discovery Funnel: In Vivo First Screening for mAb Blood-brain Barrier Penetration Yields Molecules with Novel Uptake Properties (P8-4.007)

To characterize the blood-brain barrier-crossing properties of 1,000 antibodies using a novel high-throughput, multiplexed in vivo screening platform.